Basic Information:
VIRBase ID: HHID00105043
Virus: SARS-CoV-2
Host: Homo sapiens
Confidence Score: 0.9526
Interaction Type: Host-Host interaction
Interactor Information:
Interactor1
Interactor2
Symbol
hsa-miR-203
CXCL8
miRBase Accession/Entrez ID
hsa-miR-203
3576
Organism
Homo sapiens
Homo sapiens
Category
miRNA
mRNA
Alias
-
GCP-1//GCP1//IL8//LECT//LUCT//LYNAP//MDNCF//MONAP//NAF//NAP-1//NAP1//SCYB8
RNA Modification:
Resource
Symbol
ModificationPosition
Type
Genomic Context
PMID
RMBase
CXCL8
RNA Localization:
Resource
Symbol
Subcellular Localization
Tissue or Cell Line
PMID
RNALocate
CXCL8
Related Drug Information:
Resource
Symbol
Drug Name
PubChem ID
RNAactDrug
hsa-miR-203
Interaction Network (The top 100 interactions) :
Interactor1: hsa-miR-203
Interactor2: CXCL8
Evidence Support:
Strong-Evidence
3′UTR Dual luciferase reporter assay//qRT-PCR//Western blot
Support Database
ViRBase
References:
PMID
33675361
Target region
None
Source
ViRBase
Interactor1 expression
Downregulation
Tissue or cell line
Radioresistant human NPC cells
Interactor2 expression
Upregulation
Description
In the current study, available miRNAs that regulate drug targets for treating COVID-19 in clinical trials are summarized in Table 2. miRNAs regulate the clinical targets of SARS-CoV-2 in TTD.